EquiReason research coverage

Cellebrite DI Ltd. CLBT

Technology · Software - Application

4quarters analysed

12SEC filings read

5segments identified

10institutional managers tracked

Product lines it reports

The product and service lines Cellebrite DI Ltd. breaks its revenue into.

Subscription Services
Term Licenses
Professional Services
Other Non Recurring

Where its revenue is reported

The geographies Cellebrite DI Ltd. reports revenue for. How much comes from each is in the product.

Americas
EMEA
Asia Pacific

What we read

The sources behind this company, and how many records of each we hold.

Financial statements27
Quarterly metric series12
Business segments5
SEC filings12
Insider transactions (Form 4)6
Institutional positions (13F)7
Earnings quality checks6
Estimate revisions11
GAAP vs non-GAAP reconciliation1
Seasonal pattern6
Multi-period trajectory7
Fiscal calendar1
Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

Revenue series4
Earnings series4
Guidance changesnot found
Margin seriesnot found
Cash flow seriesnot found
Per-share seriesnot found
Operating cash flow seriesnot found

This page says how much of Cellebrite DI Ltd. we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open CLBT in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies